Affluent Partners Holdings Ltd (HK:1466)
:1466
Top Page
Affluent Partners Holdings
(1466)
Select Model
Select Model
Rating:46Neutral
Price Target:
HK$0.64
▲(17.59% Upside)
Action:ReiteratedDate:03/24/26
The score is primarily weighed down by weak financial performance—ongoing losses, a rapid debt build, and sustained negative free cash flow despite the 2025 revenue rebound. Technicals are supportive due to price strength above key moving averages and a positive MACD, but overbought RSI/Stoch conditions add near-term risk. Valuation provides limited support given the high P/E and no dividend yield data.
Positive Factors
Top-line recovery
A 36% revenue rebound in 2025 signals durable demand recovery and improved scale for the luxury business. Stronger top-line momentum supports inventory turn, purchasing leverage and longer-term revenue visibility, reducing execution risk if sustained over multiple quarters.
Negative Factors
Rapid increase in debt
Debt surged meaningfully in two years, materially increasing financial obligations and interest exposure. Rapid leverage expansion with still-negative returns raises refinancing and covenant risk, constraining strategic options and raising the bar for consistent cash profitability to service debt.
Read all positive and negative factors
Positive Factors
Negative Factors
Top-line recovery
A 36% revenue rebound in 2025 signals durable demand recovery and improved scale for the luxury business. Stronger top-line momentum supports inventory turn, purchasing leverage and longer-term revenue visibility, reducing execution risk if sustained over multiple quarters.
Read all positive factors
Affluent Partners Holdings (1466) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$596.64M
Dividend YieldN/A
Average Volume (3M)304.34K
Price to Earnings (P/E)49.8
Beta (1Y)0.17
Revenue Growth20.46%
EPS GrowthN/A
CountryHK
Employees84
SectorConsumer Cyclical
Sector Strength84
IndustryLuxury Goods
Share Statistics
EPS (TTM)<0.01
Shares Outstanding932,254,100
10 Day Avg. Volume457,992
30 Day Avg. Volume304,341
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)4.22
Price to Sales (P/S)7.57
P/FCF Ratio-61.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Affluent Partners Holdings Business Overview & Revenue Model
Company Description
Affluent Partners Holdings Limited, an investment holding company, engages in the purchase, process, design, production, assembly, trade, and wholesale distribution of pearls and jewelry products. It operates in two segments, Sales of Pearls and J...
Affluent Partners Holdings Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
46
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 119.80M | 135.56M | 86.88M | 62.65M | 43.32M | 111.98M |
| Gross Profit | 33.67M | 41.99M | 7.83M | 10.99M | -8.62M | 28.55M |
| EBITDA | 10.47M | 6.26M | 11.13M | -9.73M | -45.45M | -268.12M |
| Net Income | 8.08M | -316.00K | 8.73M | -15.46M | -51.78M | -281.82M |
Balance Sheet | ||||||
| Total Assets | 281.67M | 290.17M | 99.85M | 82.11M | 91.77M | 158.66M |
| Cash, Cash Equivalents and Short-Term Investments | 57.46M | 47.77M | 41.26M | 23.59M | 24.42M | 34.49M |
| Total Debt | 85.43M | 99.93M | 2.76M | 31.84M | 31.56M | 39.50M |
| Total Liabilities | 123.85M | 134.30M | 21.51M | 46.24M | 45.82M | 73.53M |
| Stockholders Equity | 140.88M | 139.28M | 78.34M | 35.87M | 45.95M | 85.13M |
Cash Flow | ||||||
| Free Cash Flow | -15.37M | -32.97M | -21.55M | 1.06M | -16.21M | -1.29M |
| Operating Cash Flow | -13.21M | -30.53M | -21.52M | 1.11M | -16.18M | 2.33M |
| Investing Cash Flow | -1.17M | -846.00K | 35.30M | -60.00K | 138.00K | 39.15M |
| Financing Cash Flow | 25.72M | 41.41M | 3.70M | -1.72M | 6.77M | -35.22M |
Affluent Partners Holdings Technical Analysis
Positive
0.54
Price Trends
0.56
Positive
0.56
Positive
0.58
Positive
Market Momentum
0.02
Negative
60.47
Neutral
74.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1466, the sentiment is Positive. The current price of 0.54 is below the 20-day moving average (MA) of 0.59, below the 50-day MA of 0.56, and below the 200-day MA of 0.58, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 60.47 is Neutral, neither overbought nor oversold. The STOCH value of 74.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1466.
Affluent Partners Holdings Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.29B | 3.61 | 5.10% | 4.05% | 6.60% | -14.32% | |
70 Outperform | HK$1.60B | 4.06 | 10.00% | 9.67% | -9.00% | -21.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
50 Neutral | HK$783.92M | 4.39 | -1.15% | ― | -41.44% | -209.76% | |
49 Neutral | HK$598.03M | -12.90 | -68.76% | ― | -20.65% | -616.18% | |
48 Neutral | HK$374.26M | -11.47 | -7.92% | ― | -18.07% | -1041.89% | |
46 Neutral | HK$596.64M | 49.76 | 7.10% | ― | 20.46% | ― |
* Consumer Cyclical Sector Average
HK:1466
Affluent Partners Holdings
0.64
0.00
0.00%
HK:0256
Citychamp Watch & Jewellery Group
0.09
-0.30
-77.95%
HK:0887
Emperor Watch & Jewellery
0.32
0.13
74.03%
HK:3389
Hengdeli Holdings
0.18
0.09
93.48%
HK:0398
Oriental Watch Holdings
3.29
0.37
12.63%
HK:1856
Ernest Borel Holdings Ltd
1.66
0.38
29.69%
Affluent Partners Holdings Corporate Events
Baijin Life Science Adds Independent Director to Restore Governance Compliance
Mar 2, 2026
Baijin Life Science Holdings has appointed Ms. Shen Ding as an independent non‑executive director and member of its audit, remuneration and nomination committees, effective 2 March 2026. Shen brings experience in equity investment, asset man...
Baijin Life Science Clarifies Board and Committee Roles in Governance Update
Mar 2, 2026
Baijin Life Science Holdings has released an updated list of its directors and clarified the composition of its three key board committees. The announcement confirms the roles of executive, non-executive and independent non-executive directors, wi...
Baijin Life Science Director Resigns, Triggering Temporary Governance Non-Compliance
Jan 27, 2026
Baijin Life Science Holdings has announced the resignation of independent non-executive director (INED) Mr. Lee Ka Leung Daniel, who has also stepped down as chairman of the audit committee and as a member of the remuneration and nomination commit...
Baijin Life Science Sets Out Board and Committee Structure
Jan 27, 2026
Baijin Life Science Holdings Limited has announced the composition of its board of directors, comprising executive, non-executive and independent non-executive directors, as well as the structure of its three key board committees. The company has ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.